Dexamethasone sodium phosphate 0.1%; oph soln; contains benzalkonium chloride. Initial therapy: 1 or 2 drops in conjunctival sac every hour during the day and every two hours during the night.

Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Metastatic Pancreatic Cancer.

Dexamethasone phosphate (as sodium); 4mg/mL, 10mg/mL; soln for IV or IM inj; contains sulfites. Potentiated by CYP3A4 inhibitors (eg, ketoconazole, macrolides), cyclosporine, estrogens.

DEXAMETHASONE VIATRIS contains the active ingredient dexamethasone phosphate (as sodium). It may be used to treat an inactive or underactive adrenal gland or to treat a number of different ...

Polyethylene glycol, polysorbate 80, monobasic sodium phosphate ... 17,21-dipropionate 1% in petrolatum, dexamethasone-21-phosphate disodium salt 1% in petrolatum, and clobetasol-17-propionate ...